Features
28
My Approach
Medullary
thyroid cancer
and its primary
treatment
30
Q & A
Critical issues in
thoracic oncology
Conference
10
American
Society
of Clinical
Oncology 2017
Annual Meeting
10
Practice changers in advanced
prostate cancer: STAMPEDE, LATITUDE
vis-à-vis CHAARTED
11
Practice changers in breast cancer
14
Ten practice changes I will make after
attending ASCO 2017
16
New standard of care for low risk
stage 3 colorectal cancer?
17
Extent of lymph node dissection in
prostatectomy: an update
18
Significant updates in glioblastoma
20
Novel treatment options for RCC: a
review
20
Practice changers in myeloma
Cover
6
Consensus
conference on
de-escalating
and escalating
treatments for
early-stage
breast cancer
RESEARCH
Editor’s picks
6
Consensus conference
on de-escalating and
escalating treatments for
early-stage breast cancer
7
Dabrafenib plus
trametinib in patients
with BRAF(V600)-
mutant melanoma brain
metastases (COMBI-MB)
8
Adjuvant pertuzumab
and trastuzumab in early
HER2+ breast cancer
9
Surgical resection vs
watchful waiting in low-
grade glioma
Breast
22
Risks of breast, ovarian,
and contralateral breast
cancer for BRCA1- and
BRCA2-mutation carriers
Melanoma
23
Adoptive transfer
of tumor-infiltrating
lymphocytes for metastatic
uveal melanoma
Colon & Rectum
24
Clinical implications of
monitoring circulating
tumor DNA in patients with
colorectal cancer
24
First-line chemotherapy
combined with cetuximab
or bevacizumab for KRAS
wild-type advanced or
metastatic colorectal
cancer
Genitourinary
26
Liquid biopsy analysis
of FGFR3 and PIK3CA
hotspot mutations for
disease surveillance in
bladder cancer
27
Similar oncological
outcomes with partial and
radical nephrectomy in
RCC ≥4 cm
PracticeUpdate Oncology
is
published by Elsevier Australia
ISSN 2207-869X (Print) ISSN 2207-8703 (Online)
ABN 70 001 002 357
475 Victoria Avenue
Chatswood NSW 2067 Australia
Locked Bag 7500 Chatswood DC NSW 2067
EMON071701
PracticeUpdate is guided by a world-renowned
Editorial and Advisory Board that represents
community practitioners and academic specialists
with cross-disciplinary expertise.
Editor-in-Chief
Lee Schwartzberg MD FACP
Associate Editors
Isabel Cunningham MD
Axel Grothey MD
Advisory Board
Kimberly Blackwell MD,
Roxana Dronca MD, Wilfried Eberhardt MD,
Rafael Fonseca MD, Andre Goy MD,
Annette Hasenburg Prof Dr med, David Henry MD,
Eric Jonasch MD, Jeffrey Kirshner MD, FACP,
Ruben Niesvizky MD, Howard Scher MD,
David Straus MD, Roger Stupp MD
Editorial Contributors
Brandt Esplin MD PhD,
Jeremy Jones MD, Jarushka Naidoo MD,
Moshe Ornstein MD, Erin Schenk MD PhD
PracticeUpdate® is a registered trademark of Elsevier
Inc. © 2017 Elsevier Inc. All rights reserved.
ABOUT
PracticeUpdate Oncology
provides coverage of key
research from leading international conferences, and
a collection of top journal articles and accompanying
expert commentaries in a convenient print periodical.
These and more are also available online at www.
practiceupdate.comPracticeUpdate and
PracticeUpdate Oncology
are commercially supported by advertising,
sponsorship, and educational grants. Individual access
to
PracticeUpdate.comis free. Premium content is
available to any user who registers with the site.
While PracticeUpdate is a commercially-sponsored
product, it maintains the highest level of academic
rigour, objectivity, and fair balance associated with all
Elsevier products. No editorial content is influenced
in any way by commercial sponsors or content
contributors.
DISCLAIMER
PracticeUpdate Oncology
has been developed
for specialist medical professionals. The ideas
and opinions expressed in this publication do not
necessarily reflect those of the Publisher. Elsevier will
not assume responsibility for damages, loss, or claims
of any kind arising from or related to the information
contained in this publication, including any claims
related to the products, drugs, or services mentioned
herein. Because of rapid advances in the medical
sciences, in particular, independent verification
of diagnoses and drug dosages should be made.
Please consult the full current Product Information
before prescribing any medication mentioned in this
publication.
Although all advertising material is expected to
conform to ethical (medical) standards, inclusion in
this publication does not constitute a guarantee or
endorsement of the quality or value of such product or
of the claims made of it by its manufacturer.
SALES
Fleur Gill
fleur.gill@elsevier.comLinnea Mitchell-Taverner
l.mitchell@elsevier.comPRODUCTION
Editorial Manager
Anne Neilson
anne.neilson@elsevier.comEditorial Project Manager
Carolyn Ng
Designer
Jana Sokolovskaja
Cover: Dividing breast cancer cell.
CONTENTS
5
VOL. 1 • NO. 2 • 2017